Zentalis Pharmaceuticals, Inc.

NasdaqGM:ZNTL Stock Report

Market Cap: US$309.6m

Zentalis Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ZNTL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 May 24SellUS$42,353Diana HausmanIndividual3,356US$12.62
02 Feb 24SellUS$18,291Mark LacknerIndividual1,585US$11.54
02 Feb 24SellUS$38,197Andrea PaulIndividual3,310US$11.54
13 Nov 23BuyUS$51,448Kimberly BlackwellIndividual5,000US$10.29
10 Nov 23BuyUS$167,943David JohnsonIndividual17,000US$9.88

Insider Trading Volume

Insider Buying: ZNTL insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZNTL?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,685,9271.93%
Hedge Funds17,812,40220.4%
Institutions67,793,40377.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 112.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.7%
Matrix Capital Management Company, LP
13,959,973US$60.9m0%0.49%
16.3%
Eventide Asset Management, LLC
11,574,821US$50.5m0.13%0.82%
15%
FMR LLC
10,644,024US$46.4m2.97%no data
9.59%
T. Rowe Price Group, Inc.
6,808,795US$29.7m29.8%no data
6.54%
BlackRock, Inc.
4,645,758US$20.3m-0.84%no data
6.19%
The Vanguard Group, Inc.
4,398,625US$19.2m-17.8%no data
5.42%
Citadel Advisors LLC
3,852,429US$16.8m4.63%0.02%
5.33%
State Street Global Advisors, Inc.
3,785,652US$16.5m-14.3%no data
3.97%
Capital Research and Management Company
2,819,664US$12.3m0%no data
2.96%
Decheng Capital LLC
2,099,583US$9.2m0%2.72%
2.81%
Federated Hermes, Inc.
1,998,700US$8.7m-7.49%0.02%
2.14%
BioImpact Capital LLC
1,516,183US$6.6m0%1.0%
2.02%
Woodline Partners LP
1,437,026US$6.3m2.38%0.06%
1.83%
Geode Capital Management, LLC
1,302,237US$5.7m3.87%no data
1.64%
PRIMECAP Management Company
1,164,610US$5.1m13.8%no data
1.63%
Verition Fund Management LLC
1,155,236US$5.0m235%0.05%
1.43%
Morgan Stanley, Investment Banking and Brokerage Investments
1,016,400US$4.4m70.2%no data
1.35%
Tybourne Capital Management (HK) Ltd.
961,486US$4.2m0%0.72%
1.33%
Paradigm Biocapital Advisors LP
944,917US$4.1m136%0.14%
1.2%
Kevin Bunker
850,281US$3.7m21.6%no data
1.02%
Dimensional Fund Advisors LP
723,656US$3.2m-0.05%no data
0.74%
Northern Trust Global Investments
523,702US$2.3m-1.19%no data
0.69%
5AM Venture Management, LLC
490,000US$2.1m0%0.4%
0.66%
Bank of America Corporation, Asset Management Arm
465,956US$2.0m-34.3%no data
0.64%
Charles Schwab Investment Management, Inc.
455,937US$2.0m0%no data
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.